Federated Hermes Portfolio holdings
AUM
$53.1B
This Quarter Return
-3.68%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$44.3B
AUM Growth
+$44.3B
(-17%)
Cap. Flow
-$5.54B
Cap. Flow
% of AUM
-12.51%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
213
Increased
802
Reduced
969
Closed
240
Top Buys
| 1 |
S&P Global
SPGI
|
$160M |
| 2 |
Clorox
CLX
|
$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
$134M |
| 4 |
Pfizer
PFE
|
$108M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$101M |
Top Sells
| 1 |
TSMC
TSM
|
$903M |
| 2 |
Chevron
CVX
|
$268M |
| 3 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$257M |
| 4 |
Exxon Mobil
XOM
|
$238M |
| 5 |
AbbVie
ABBV
|
$205M |
Sector Composition
| 1 | Healthcare | 22.63% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.52% |
| 4 | Consumer Discretionary | 8.91% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $746M | 1.68% | 2,418,607 +22,964 | +1% | +$7.08M |
|
2
Apple
AAPL
$3.45T
| $712M | 1.61% | 4,079,912 +2,509 | +0.1% | +$438K |
|
|
3
AbbVie
ABBV
$372B
| $632M | 1.43% | 3,900,939 -1,264,452 | -24% | -$205M |
|
|
4
Chevron
CVX
$324B
| $599M | 1.35% | 3,678,173 -1,645,751 | -31% | -$268M |
|
5
Alphabet (Google) Class A
GOOGL
$2.57T
| $582M | 1.31% | 209,179 -14,818 | -7% | -$41.2M |
|
|
6
Exxon Mobil
XOM
$487B
| $516M | 1.17% | 6,253,447 -2,884,230 | -32% | -$238M |
|
7
Philip Morris
PM
$260B
| $479M | 1.08% | 5,100,156 -201,769 | -4% | -$19M |
|
8
Amazon
AMZN
$2.44T
| $473M | 1.07% | 145,055 -16,473 | -10% | -$53.7M |
|
9
Verizon
VZ
$186B
| $464M | 1.05% | 9,114,174 +696,744 | +8% | +$35.5M |
|
10
Merck
MRK
$210B
| $452M | 1.02% | 5,509,801 -633,910 | -10% | -$52M |
|
11
Gilead Sciences
GILD
$140B
| $414M | 0.94% | 6,966,697 +588,734 | +9% | +$35M |
|
12
Southern Company
SO
$102B
| $399M | 0.9% | 5,502,146 -1,059,691 | -16% | -$76.8M |
|
|
13
Bristol-Myers Squibb
BMY
$96B
| $371M | 0.84% | 5,077,139 +1,839,065 | +57% | +$134M |
|
14
Amgen
AMGN
$155B
| $359M | 0.81% | 1,484,974 -58,433 | -4% | -$14.1M |
|
15
Duke Energy
DUK
$95.3B
| $351M | 0.79% | 3,140,290 -1,612,437 | -34% | -$180M |
|
|
16
Pfizer
PFE
$141B
| $344M | 0.78% | 6,643,171 +2,091,343 | +46% | +$108M |
|
17
DexCom
DXCM
$29.5B
| $318M | 0.72% | 621,135 -172 | -0% | -$88K |
|
18
Credicorp
BAP
$20.4B
| $315M | 0.71% | 1,831,071 +41 | +0% | +$7.05K |
|
19
Dominion Energy
D
$51.1B
| $314M | 0.71% | 3,699,653 -303,074 | -8% | -$25.8M |
|
20
General Mills
GIS
$26.4B
| $305M | 0.69% | 4,497,372 -467,231 | -9% | -$31.6M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $290M | 0.65% | 3,987,728 +858 | +0% | +$62.3K |
|
22
ServiceNow
NOW
$190B
| $274M | 0.62% | 492,915 -17,105 | -3% | -$9.53M |
|
23
Huntington Bancshares
HBAN
$26B
| $268M | 0.61% | 18,352,191 +3,149,952 | +21% | +$46.1M |
|
24
AT&T
T
$209B
| $267M | 0.6% | 11,316,727 +2,051,264 | +22% | +$48.5M |
|
25
Trane Technologies
TT
$92.5B
| $259M | 0.58% | 1,694,649 -65,848 | -4% | -$10.1M |
|